Innovative method differentiates Parkinson's from MS
A team of researchers at Shanghai University has developed a new technique that accurately distinguishes between Parkinson's disease and multiple system atrophy by monitoring a biomarker in cerebrospinal fluid. The results showed that samples from patients with multiple system atrophy exhibited a strong amplification response, while samples from Parkinson's, Alzheimer's, or dementia patients did not show similar responses. This advancement facilitates early diagnosis and reduces treatment errors associated with symptom similarity in the early stages.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)